Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal studies ...
Bavarian Nordic announced on Friday a new contract with the European Commission, allowing countries across Europe to buy up ...
A G.I. with ribbons on his chest had come back from Japan to Seattle. He brought smallpox with him. Result: the city’s worst epidemic of the “Red Death” in years.* Last week police were called out to ...
On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment TEPOXX (tecovirimat 200 mg capsules) for smallpox, mpox, cowpox, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback